Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathways in cancer | R-HSA-9824443 | map05200 | N-acetylmuramic acid | 5462244 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | N-acetylmuramic acid | 5462244 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | N-acetylmuramic acid | 5462244 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | N-acetylmuramic acid | 5462244 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | N-acetylmuramic acid | 5462244 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | bupivacaine | 2474 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | bupivacaine | 2474 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | bupivacaine | 2474 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | bupivacaine | 2474 | drug-path |
| Asthma | R-HSA-444620 | map05310 | bupivacaine | 2474 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | bupivacaine | 2474 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | bupivacaine | 2474 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | bupivacaine | 2474 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | bupivacaine | 2474 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | bupivacaine | 2474 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | piperine | 638024 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | piperine | 638024 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | piperine | 638024 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | piperine | 638024 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | piperine | 638024 | drug-path |